Alexander B. Sibley
Duke University(US)Duke Medical Center(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Lymphoma Diagnosis and Treatment, Ovarian cancer diagnosis and treatment, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502(2015)159 cited
- → Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance)(2014)87 cited
- → Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma(2019)58 cited
- → Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218(2020)57 cited
- → Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy(2016)57 cited
- → Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence(2020)47 cited
- → A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer(2021)38 cited
- → Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib(2020)29 cited
- → Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance)(2020)27 cited
- → Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi‐institutional study(2016)26 cited